MODERATOR
:
SPEAKER
(S):
Carolina Ionete, MD, PhD, Associate Professor of Clinical Neurology, Umass
MS/NMO from the View of Neurologist
A. Sergio Torloni, MD, Medical Director, Stem Cell Therapy, Therapeutic Apheresis, Mayo Clinic Hospital
Plasmapheresis in MS & NMO: Supporting Evidence
Bruce McLeod, MD, Director, Blood Center, Rush University Medical Center
Plasmapheresis for MS and NMO: An Unjustified Unproven Therapy
Description
Multiple sclerosis (MS) is a relapsing and often progressive disorder of the central nervous system characterized by demyelination. Some reports show that TPE is effective for acute MS; however, TPE is often performed for non-acute phase MS patients who are unresponsive to steroids with lack of evidence of effectiveness. On the other hand, NMO is considered as an autoimmune disease associated with NMO-IgG. The effect of TPE on NMO patients is not consistent and the demyelination of optic nerve can be a part of MS. This session will discuss controversial application of TPE on both diseases.
-
Assess clinical response to therapeutic plasma exchange (TPE) on variable types of MS and NMO patients.
-
Describe current clinical understanding of multiple sclerosis (MS) and neuromyelitis optica (NMO).
-
Discuss controversial TPE treatment for MS/NMO patients.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.